RK

Ringku Kumari

Active Director Director DIN 10107202
DIN 10107202 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Ringku Kumari

Data last updated:

Ringku Kumari is a Director at Biosense Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Biosense Pharmaceuticals Private Limited reported revenue of ₹2.1 Lakh (FY 2024).

DIN 10107202
Primary Designation Director
Industry Pharma
First Appointment 10 Apr 2023
Oldest Company Age 3 yrs
Largest company Biosense Pharmaceuticals Private Limited · ₹2.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Apr 20232023₹2.1 Lakh (FY 2024)Active

Board colleagues of Ringku Kumari

Directorship timeline

Open interactive timeline →
Biosense Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ringku Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ringku Kumari

Ringku Kumari currently holds 1 directorship: Biosense Pharmaceuticals Private Limited (Director, since 10 Apr 2023, revenue ₹2.1 Lakh (FY 2024)).

Ringku Kumari was first appointed on 10 Apr 2023 as Director at Biosense Pharmaceuticals Private Limited.

The current boards of Ringku Kumari's companies include Pankaj Kumar Singh (Biosense Pharmaceuticals Private Limited), Rahul Kumar (Biosense Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available